NDC 12634-790

Glipizide

Glipizide

Glipizide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Apotheca Inc.. The primary component is Glipizide.

Product ID12634-790_463dc8c9-618d-0759-e054-00144ff88e88
NDC12634-790
Product TypeHuman Prescription Drug
Proprietary NameGlipizide
Generic NameGlipizide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-07-18
Marketing CategoryANDA / ANDA
Application NumberANDA074550
Labeler NameApotheca Inc.
Substance NameGLIPIZIDE
Active Ingredient Strength10 mg/1
Pharm ClassesSulfonylurea [EPC],Sulfonylurea Compounds [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 12634-790-00

10 TABLET in 1 BOTTLE (12634-790-00)
Marketing Start Date2011-07-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 12634-790-91 [12634079091]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-61 [12634079061]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-84 [12634079084]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-92 [12634079092]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-99 [12634079099]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-57 [12634079057]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-60 [12634079060]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-69 [12634079069]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-85 [12634079085]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-50 [12634079050]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-66 [12634079066]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-09 [12634079009]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-96 [12634079096]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-97 [12634079097]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-63 [12634079063]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-90 [12634079090]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-81 [12634079081]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-59 [12634079059]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-00 [12634079000]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-18 [12634079018]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-93 [12634079093]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-71 [12634079071]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-82 [12634079082]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-98 [12634079098]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-94 [12634079094]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-54 [12634079054]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-52 [12634079052]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-42 [12634079042]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-12 [12634079012]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-40 [12634079040]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-45 [12634079045]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-67 [12634079067]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-74 [12634079074]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-78 [12634079078]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-01 [12634079001]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-79 [12634079079]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-80 [12634079080]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

NDC 12634-790-95 [12634079095]

Glipizide TABLET
Marketing CategoryANDA
Application NumberANDA074550
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-07-18

Drug Details

Active Ingredients

IngredientStrength
GLIPIZIDE10 mg/1

OpenFDA Data

SPL SET ID:463df134-fe6d-5b08-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310488
  • Pharmacological Class

    • Sulfonylurea [EPC]
    • Sulfonylurea Compounds [CS]
    • Sulfonylurea [EPC]
    • Sulfonylurea Compounds [CS]

    NDC Crossover Matching brand name "Glipizide" or generic name "Glipizide"

    NDCBrand NameGeneric Name
    0378-1105Glipizideglipizide
    0378-1110Glipizideglipizide
    0591-0460GlipizideGlipizide
    0591-0461GlipizideGlipizide
    0591-0844GlipizideGlipizide
    0591-0845GlipizideGlipizide
    0591-0900GlipizideGlipizide
    0615-3595GlipizideGlipizide
    0615-3596GlipizideGlipizide
    0615-5584GlipizideGlipizide
    0615-5585GlipizideGlipizide
    0615-6596GlipizideGlipizide
    0615-7968GlipizideGlipizide
    0615-7969GlipizideGlipizide
    0615-8407GlipizideGlipizide
    68071-1773GlipizideGlipizide
    68071-3009GlipizideGlipizide
    68071-3141GlipizideGlipizide
    68071-4223GlipizideGlipizide
    68071-4124GlipizideGlipizide
    68071-4085GlipizideGlipizide
    68071-4378GlipizideGlipizide
    68071-4498GlipizideGlipizide
    68071-4020GlipizideGlipizide
    68071-4232GlipizideGlipizide
    68071-4643GlipizideGlipizide
    68382-337GlipizideGlipizide
    68382-336GlipizideGlipizide
    68382-335GlipizideGlipizide
    68645-575GlipizideGlipizide
    68788-0141GlipizideGlipizide
    68645-151GlipizideGlipizide
    68645-574GlipizideGlipizide
    68788-0142GlipizideGlipizide
    68788-7250GlipizideGlipizide
    68788-6853GlipizideGlipizide
    68788-6854GlipizideGlipizide
    68788-9176GlipizideGlipizide
    68788-7230GlipizideGlipizide
    68788-9918GlipizideGlipizide
    70518-0029GlipizideGlipizide
    70518-0104GlipizideGlipizide
    70518-0552GlipizideGlipizide
    70518-0115GlipizideGlipizide
    70518-0389GlipizideGlipizide
    70518-0358GlipizideGlipizide
    70518-1124GlipizideGlipizide
    70518-0998GlipizideGlipizide
    70518-1063GlipizideGlipizide
    70518-0574GlipizideGlipizide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.